跳至主要内容
临床试验/NCT02820506
NCT02820506进行中(未招募)不适用

Sentinel Node Mapping With Robotic Assisted Near Infra-red Fluorescent Imaging in Women With Cervical and Endometrial Cancer

University of Southern Denmark8 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2017年2月27日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
300
试验地点
8
主要终点
Sensitivity

研究概览

简要总结

The aim of the study is to evaluate the feasibility of applying the SLN mapping technique in combination with FDG-PET/CT imaging in women with high-risk histology endometrial cancer and in patients with cervical cancer tumour size 2-4 cm.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Study IIA: Patients with cervical cancer, FIGO IB1, tumor size 2-4 cm
  • Study IIB: Patients with high risk endometrial cancer, presumed FIGO I, type 1 histology grade 3 Endometrioid adenocarcinoma or type 2 histology (serous-, clearcel-, carcinosarcoma or undifferentiated adenocarcinoma.

排除标准

  • Known allergy towards ICG and/or iodine (ICG contains 5% sodium iodine)
  • Women included in other studies affecting outcome-measures of the present study

结局指标

主要结局

Sensitivity

时间窗: 2 years

Sensitivity of sentinel lymph node mapping compared to the sensitivity of sentinel lymph node mapping combined with removal of PET-positive lymph nodes

Negative predictive value

时间窗: 2 years

Negative predictive value of sentinel lymph node mapping algorithm, and a sentinel lymph node mapping algorithm including removal of PET-positive lymph nodes

次要结局

  • Positive predictive value(2 years)
  • Quality of life rate(3 years)
  • Specificity(2 years)
  • Incidence of lymphedema(3 years)
  • Severity of lymphedema(3 years)
  • Prevalence of lymph node metastasis(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sara Sponholtz

MD

University of Southern Denmark

研究点 (8)

Loading locations...

相似试验

Sentinel Node Mapping in Women With Endometrial and... | 临床试验